“Refractory Thrombocytopenia After 177Lu-PSMA Therapy: Bone Marrow Infiltration (myelophthisis) Versus Treatment Toxicity”. Scientific Reports in Medicine, vol. 3, no. 1, Apr. 2026, pp. 39-46, https://doi.org/10.37609/srinmed.63.